Skip to content

My Pharmacy News

mypharmacynews.com

  • Health News
  • Medications
  • Health Problems
  • Beauty & Balance
  • Personal Health

Home ยป MERCK

11/10/2021

Japan to pay $1.2 billion for 1.6 million courses of Merck's COVID-19 pill

FILE PHOTO: An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics

Continue reading »
Latest Posts
Assisted reproductive technology not tied to higher BMI in childhood, finds study
What’s the difference between physical and chemical sunscreens? And which one should you choose?
How medical manufacturing trends are evolving: From performance testing to 3D vision
Health Problems
What are Drug-Induced Nail Disorders?
Current State of Clinical Diagnostics
Machine Learning for Targeted Disease Treatment
Recent Posts
  • Assisted reproductive technology not tied to higher BMI in childhood, finds study
  • What’s the difference between physical and chemical sunscreens? And which one should you choose?
  • How medical manufacturing trends are evolving: From performance testing to 3D vision
  • New tool assesses role of ’embeddedness’ in learning health systems
  • NHS strike chaos begins as A&E unit CLOSES ahead of three-day walk-out
Copyright © 2025
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok